| Description |
1 online resource |
| Series |
Pharmacology-research, safety testing, and regulation |
|
Pharmacology-research, safety testing, and regulation series.
|
| Contents |
OPTIMIZATION OF DRUG PRESCRIBING IN ELDERLY; OPTIMIZATION OF DRUG PRESCRIBING IN ELDERLY; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; AGING, CLINICAL PHARMACOKINETIC AND PERSONALIZED PHARMACOTHERAPY; Chapter 1: WHAT IS THERAPEUTIC OPTIMIZATION SCHEDULE OF DRUGS USED IN ELDERLY?; ABSTRACT; INTRODUCTION; REFERENCES; Chapter 2: OVERVIEW OF THE COMMON GERIATRIC ILLNESS; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY; CLINIC FEATURES OF THE DISEASES IN ELDERLY PEOPLE; GERIATRIC SYNDROMES; SPECIFIC PATHOLOGIES BY ORGANS AND SYSTEMS IN THE ELDERLY PEOPLE |
|
DISEASES BY ORGANS IN THE ELDERLY PEOPLECONCLUSION; REFERENCES; Chapter 3: EFFECT OF AGE ON THE PHARMACOKINETIC OFDRUGS IN ELDERLY; ABSTRACT; INTRODUCTION; PHARMACOKINETIC CHANGES; VARIATIONS IN THE DISTRIBUTION OF DRUGS; DRUG METABOLISM; EFFECTS ON PROTEIN BINDING; RECEPTOR BINDING; CHANGES IN LIVER FUNCTION; VARIATIONS OF RENAL FUNCTION; RENAL SYSTEM, DRUG AND ELECTROLYTE; DRUG INTERACTIONS; CONCLUSION; REFERENCES; Chapter 4: USEFUL OF THE PHARMACOKINETIC STUDIES AS A BASE FORTHE ESTABLISHMENT OF THERAPEUTIC SCHEDULES; ABSTRACT; INTRODUCTION |
|
DEFINITIONS AND FUNCTIONS OF CLINICAL PHARMACOKINETICSREFERENCES; Chapter 5: MEANING OF PHARMACOKINETIC PARAMETERS; ABSTRACT; INTRODUCTION; SYSTEMIC BIOAVAILABILITY; BIOLOGICAL HALF-LIFE; APPARENT VOLUME OF DISTRIBUTION; RENAL CLEARANCE; TOTAL CLEARANCE; FACTORS INFLUENCING TREATMENT RESPONSE; REFERENCES; Chapter 6: RELEVANCE OF THE PHARMACOKINETIC APPLIED IN CLINIC; ABSTRACT; INTRODUCTION; MAIN ELEMENTS IN PHARMACOKINETICS; BASICS; MEANING OF THE VOLUME OF DISTRIBUTION IN THE CLINIC; MEANING OF DRUG ELIMINATION IN THE CLINIC; MEANING OF TOTAL CLEARANCE IN THE CLINIC |
|
MEANING OF DEEP COMPARTMENT IN CLINICPHARMACOKINETICS APPLICATIONS IN CLINIC; REFERENCES; Chapter 7: DIFFERENT METHODS USED TO DETERMINE THE PHARMACOKINETICS PARAMETERS; ABSTRACT; INTRODUCTION; APPLYING THE CONCEPTS TO EVALUATE PHARMACOKINETIC AND OPTIMIZATION OF THERAPEUTIC REGIMENS; DRUG ACCUMULATION; DOSE ADJUSTMENT FOR A THERAPEUTIC REGIMEN OF REPEATED ADMINISTRATION; SUSTAINED THERAPEUTIC CONCENTRATIONS; REFERENCES; Chapter 8: PHARMACOKINETICS STUDIES AND THE INTERPRETATION OF DRUG LEVELS IN STEADY STATE; ABSTRACT; INTRODUCTION; CLINICAL INTERPRETATION OF THE LEVELS IN THE STEADY STATE |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Description based on print version record |
| Subject |
Geriatric pharmacology.
|
|
Scheduling.
|
|
Chemotherapy.
|
|
Older people.
|
|
Drug Therapy
|
|
Aged
|
|
Aged, 80 and over
|
|
elderly.
|
|
MEDICAL / Pharmacology
|
|
Older people
|
|
Chemotherapy
|
|
Scheduling
|
|
Geriatric pharmacology
|
| Form |
Electronic book
|
| Author |
Juárez Olguín, Hugo, editor
|
|
Lares Asseff, Ismael, editor
|
| LC no. |
2019720647 |
| ISBN |
9781634848961 |
|
1634848969 |
|
